It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Weizmann Institute of Science, Molecular Cell Biology Department, Rehovot, Israel (GRID:grid.13992.30) (ISNI:0000 0004 0604 7563)
2 The Scripps Research Institute, Department of Neuroscience, FL, USA (GRID:grid.214007.0) (ISNI:0000000122199231)
3 The Hebrew University, Institute of Biochemistry, Food Science and Nutrition, The Robert H. Smith Faculty of Agriculture, Food, and Environment, Rehovot, Israel (GRID:grid.9619.7) (ISNI:0000 0004 1937 0538)
4 University of Sydney, Melanoma Institute Australia, NSW, Australia (GRID:grid.1013.3) (ISNI:0000 0004 1936 834X); Royal Prince Alfred Hospital, Tissue Pathology and Diagnostic Oncology, NSW, Australia (GRID:grid.413249.9) (ISNI:0000 0004 0385 0051)
5 US National Institutes of Health, National Human Genome Research Institute, Bethesda, USA (GRID:grid.94365.3d) (ISNI:0000 0001 2297 5165)
6 Technion-Israel Institute of Technology, Department of Biology, Haifa, Israel (GRID:grid.6451.6) (ISNI:0000000121102151)
7 US National Institutes of Health, National Cancer Institute, Surgery Branch, Bethesda, USA (GRID:grid.94365.3d) (ISNI:0000 0001 2297 5165)
8 Faculty of Natural Sciences, University of Haifa, Department of Human Biology, Haifa, Israel (GRID:grid.18098.38) (ISNI:0000 0004 1937 0562)
9 University of Sydney, Melanoma Institute Australia, NSW, Australia (GRID:grid.1013.3) (ISNI:0000 0004 1936 834X); QIMR Berghofer Medical Research Institute, Brisbane, Australia (GRID:grid.1049.c) (ISNI:0000 0001 2294 1395)
10 University of Sydney, Melanoma Institute Australia, NSW, Australia (GRID:grid.1013.3) (ISNI:0000 0004 1936 834X); Royal Prince Alfred Hospital, Tissue Pathology and Diagnostic Oncology, NSW, Australia (GRID:grid.413249.9) (ISNI:0000 0004 0385 0051); Sydney Medical School, The University of Sydney, Disciplines of Surgery and Pathology, Sydney, Australia (GRID:grid.1013.3) (ISNI:0000 0004 1936 834X)